- Title
- PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer
- Creators - without role
- Mathilde Guerin - InsermKeyvan Rezai - Hôpital René HugueninNicolas Isambert - Centre Georges François LeclercMario Campone - Institut de Cancérologie de l'OuestAurélie Autret - Institut Paoli-CalmettesJihane Pakradouni - Institut Paoli-CalmettesMagali Provansal - Institut Paoli-CalmettesJacques Camerlo - Institut Paoli-CalmettesRenaud Sabatier - Institut Paoli-CalmettesFrançois Bertucci - Aix-Marseille UniversitéEmmanuelle Charafe-Jauffret - Institut Paoli-CalmettesAlice Hervieu - Centre Georges François LeclercJean-Marc Extra - Institut Paoli-CalmettesPatrice Viens - Institut Paoli-CalmettesFrançois Lokiec - Hôpital René HugueninJean-Marie Boher - Centre de Recherche en Cancérologie de MarseilleAnthony Gonçalves - Institut Paoli-Calmettes
- Publication Details
- European Journal of Cancer, Vol.86, pp.28-36
- Identifiers
- 9934588409311
- Academic Unit
- Université de Montpellier
- Language
- English
- Resource Type
- Journal article
- Local Fields
- hal-03623711
Journal article
PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer
European Journal of Cancer, Vol.86, pp.28-36
11/2017
Metrics
1 Record Views